Article
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
23 Mar 2021
Abstract excerpt
Introduction Detection of abnormalities in the KRAS, NRAS and BRAF genes is extremely important for proper qualification of colorectal cancer (CRC) patients for therapy with anti-EGFR (epidermal growth factor receptor) monoclonal antibodies. However, data about prevalence of mutations in these genes, in different localizations of CRC tumors, are limited. Material and methods We examined the frequency of mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
